Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
501 Leser
Artikel bewerten:
(2)

Everdrone AB: For the first time in medical history, an autonomous drone helps save the life of a cardiac arrest patient

For the first time in medical history, a drone has played a crucial part in saving a life during a sudden cardiac arrest. The world unique achievement took place in Trollhättan, Sweden in December of 2021, when an Everdrone autonomous drone delivered a defibrillator that helped save the life of a 71-year-old man.

"This is a truly revolutionary technology that needs to be implemented all over", says the patient who now has made a full recovery.

GOTHENBURG, Sweden, Jan. 4, 2022 /PRNewswire/ -- Everdrone's Emergency Medical Aerial Delivery service (EMADE), an innovative link in the chain of life-saving measures of Region Västra Götaland, Sweden, was put to the toughest of tests in the morning of December the 9th of 2021. In the Swedish city of Trollhättan, a 71-year-old man was shoveling snow in his driveway when he suffered an out-of-hospital cardiac arrest (OHCA). Thanks to the combination of an immediate emergency call, the quick actions of Dr. Mustafa Ali and the swift delivery of an Automated External Defibrillator (AED), lifesaving measures through defibrillation could be initiated before the arrival of the ambulance, and his life was saved. The time from the alarm until the AED was safely delivered at the doorstep of the incident address was just over three minutes. After the initial treatment on site, the patient was rushed to the hospital and is today fully recovered.

Everdrone AED drone Photo Everdrone AB

"I can't put into words how thankful I am to this new technology and the speedy delivery of the defibrillator. If it wasn't for the drone I probably wouldn't be here", says the 71-year-old patient who has made a full recovery and now has been able to return to his home.

For Dr. Mustafa Ali the experience was just as gratifying, despite the gravity of the situation.

"I was on my way to work at the local hospital when I looked out the car window and saw a man collapsed in his driveway", says Dr. Ali. "I immediately understood that something was wrong and rushed to help. The man had no pulse, so I started doing CPR (cardiopulmonary resuscitation) while asking another bystander to call 112 (the Swedish emergency number). Just minutes later, I saw something flying above my head. It was a drone with a defibrillator!"

Thanks to Dr. Ali, and the use of the defibrillator, life-saving treatment was initiated early and, which in the end, meant that the life of the patient was saved.

"This is a truly revolutionary technology that needs to be implemented all over; sudden cardiac arrests can happen to anyone, not just old people with arteriosclerosis" says the patient.

The drone delivery system in Region Västra Götaland is developed and operated by Everdrone, a world-leading company in autonomous drone solutions. The solution has been developed and is continuously improved in close collaboration with Center for Resuscitation Science at Karolinska Institutet, SOS Alarm and Region Västra Götaland. The operations are also supported by Vinnova, Swelife and Medtech4Health.

"This is an excellent real-world example of how Everdrone's cutting-edge drone technology, fully integrated with emergency dispatch, can minimize the time for access to life-saving AED equipment", says Mats Sällström, CEO of Everdrone.

Approximately 275,000 patients in Europe and 350,000 in the US, suffer from OHCA annually. Approximately 70% of OHCAs occur in private homes without AEDs on site, and ambulance response times are often too long to save the life of the patient. The chance of survival decreases by 7-10% with each minute following the collapse, and consequently, the current survival rate among OHCA patients is merely 10%. Everdrone's innovative airborne AED delivery service is a proven method to tackle this critical issue. The service can currently reach 200,000 residents in Sweden and is expected to expand to more locations in Europe during 2022.

The drone system has been scientifically established to cut response times and the full study is published in the European Heart Journal.

https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehab498/6358076

Press material

Still images: https://www.dropbox.com/sh/ip89s2sxvetp9sv/AAALHexCDMZfD9HzMhz0RbtNa?dl=0

Edited video (ready for publishing): https://www.dropbox.com/sh/3hfj31oxg1g2j9z/AABe6mx57MNLtb0sjTbIpBeWa?dl=0

Unedited video material (for local editing): https://www.dropbox.com/sh/ka2a5d4nsz89i5r/AACoV25vLnbxgjAMrVVw5pHya?dl=0

About Everdrone

Everdrone AB develops technology for autonomous drones and offers advanced drone services. The company's test and development facilities are located at Sisjön, Gothenburg. The company focuses on civil applications, primarily related to healthcare and emergency response. Everdrone actively works with regulatory issues associated with drones, specializing in operations in urban areas. For more information, please visit https://everdrone.com

Logo: https://mma.prnewswire.com/media/1719658/Everdrone_Logo.jpg
Image: https://mma.prnewswire.com/media/1719659/Everdrone_AB.jpg

Everdrone Logo

Contact information:
Mats Sällström
CEO Everdrone
Mobile +46 (0) 702 28 10 95
Email mats@everdrone.com

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.